Inhibition of Hepatocellular Cancer by EB1089 : In Vitro and In Vivo StudyGHOUS, Zahid; AKHTER, Javed; POURGHOLAMI, Mohammad H et al.Anticancer research. 2008, Vol 28, Num 6A, pp 3757-3761, issn 0250-7005, 5 p.Article

Bioavailability of seocalcitol. II Development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglyceridesGROVE, Mette; MÜLLERTZ, Anette; NIELSEN, Jeanet Løgsted et al.European journal of pharmaceutical sciences. 2006, Vol 28, Num 3, pp 233-242, issn 0928-0987, 10 p.Article

Differential skeletal responses of hindlimb unloaded rats on a vitamin D-deficient diet to 1,25-dihydroxyvitamin D₃ and its analog, seocalcitol (EB1089)NARAYANAN, Ramesh; ALLEN, Matthew R; GADDY, Dana et al.Bone (New York, NY). 2004, Vol 35, Num 1, pp 134-143, issn 8756-3282, 10 p.Article

Effects of calcitriol, seocalcitol, and medium-chain triglyceride on a canine transitional cell carcinoma cell lineKAEWSAKHORN, Thattawan; KISSEBERTH, William C; CAPEN, Charles C et al.Anticancer research. 2005, Vol 25, Num 4, pp 2689-2696, issn 0250-7005, 8 p.Article

Bioavailability of seocalcitol I: Relating solubility in biorelevant media with oral bioavailability in rats : Effect of medium and long chain triglyceridesGROVE, Mette; PEDERSEN, Gitte P; NIELSEN, Jeanet L et al.Journal of pharmaceutical sciences. 2005, Vol 94, Num 8, pp 1830-1838, issn 0022-3549, 9 p.Article

Effects of Seocalcitol (EB1089) on nitrosomethyl urea-induced rat mammary tumorsCOLSTON, K. W; PIRIANOV, G; BRAMM, E et al.Breast cancer research and treatment. 2003, Vol 80, Num 3, pp 303-311, issn 0167-6806, 9 p.Article

Pharmacokinetics and metabolism of a vitamin D analogue (Seocalcitol) in rat and minipigKISSMEYER, A.-M; MORTENSEN, J. T.Xenobiotica (London. Print). 2000, Vol 30, Num 8, pp 815-830, issn 0049-8254Article

Antioxidants and doxorubicin supplementation to modulate CD14 expression and oxidative stress induced by vitamin D₃ and seocalcitol in HL60 cellsBONDZA-KIBANGOU, Patrick; MILLOT, Christine; EL KHOURY, Victoria et al.Oncology reports. 2007, Vol 18, Num 6, pp 1513-1519, issn 1021-335X, 7 p.Article

A phase ii trial of the vitamin D analogue seocalcitol (EB1089) in patients with inoperable pancreatic cancerEVANS, T. R. J; COLSTON, K. W; LOFTS, F. J et al.British journal of cancer. 2002, Vol 86, Num 5, pp 680-685, issn 0007-0920Article

The tissue-specific distribution of ³H-seocalcitol (EB 1089) and ³H-calcitriol in ratsKISSMEYER, Anne-Marie; NIELSEN, Jeanet Løgsted; BINDERUP, Lise et al.Journal of steroid biochemistry and molecular biology. 2004, Vol 89-90, Num 1-5, pp 43-47, issn 0960-0760, 5 p.Conference Paper

MNU-induced mammary gland carcinogenesis: Chemopreventive and therapeutic effects of vitamin D and Seocalcitol on selected regulatory vitamin D receptor pathwaysMACEJOVA, Dana; ONDKOVA, Slavomira; JAKUBIKOVA, Lucia et al.Toxicology letters. 2011, Vol 207, Num 1, pp 60-72, issn 0378-4274, 13 p.Article

Seocalcitol (EB 1089) : A vitamin D analogue of anti-cancer potential. Background, design, synthesis, pre-clinical and clinical evaluationHANSEN, C. M; HAMBERG, K. J; BINDERUP, E et al.Current pharmaceutical design. 2000, Vol 6, Num 7, pp 803-828, issn 1381-6128Article